GCVI Summit 2018
Skip Content

27 November 2017

News round up 27 November 2017

A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

Author: Thierry Heles, editor

StartToday considers whether StretchSense fits

StartToday has taken an option on sensor manufacturer StretchSense after using the spinout’s technology for its body measurement device.

SenseTime seeks to schedule IPO

SenseTime, founded by Chinese University of Hong Kong professor Tang Xiaoou, has begun exploring an initial public offering as early as 2018.

GripAble grasps $900,000

The mobility tool spinout has received an Innovate UK grant and equity funding from backers including venture firm Oxford Technology Management.

UCD spinouts gear up for showcase

Five spinouts will pitch at the conclusion of UCD’s VentureLaunch accelerator on November 29, with one business set to receive $11,800 in cash.

TMC prescribes $25m fund

Texas Medical Center, a medical complex that includes multiple universities located in the US state, has launched a $25m fund to invest in early-stage healthcare technologies in Houston.

Coticchia to leave Pitt’s Blast Furnace

Greg Coticchia, director of University of Pittsburgh’s accelerator Blast Furnace, has decided to step down on November 30, though he will remain an adjunct professor at the institution.

Parkwalk announces fourth Oxford fund

The University of Oxford Innovation Fund IV is seeking commitments from alumni and other investors to support the Oxford ecosystem.

Kyoto strikes Chordia in series A round

Oncology drug developer Chordia Therapeutics has raised series A funding from backers including Kyoto University Innovation Capital.

Vigilant Diagnostics detects seed round

University of Minnesota spinout Vigilant Diagnostics has closed a seed round that featured an unnamed Chinese investor.

Aston Eyetech spots $6.6m series A

The ocular device spinout hopes to rapidly develop portable devices for eye testing powered by artificial intelligence software.

Shoichet becomes Ontario’s chief scientist

University of Toronto’s Molly Shoichet will advocate science research in the provincial government and promote Ontario as a research hub within Canada and globally.

Perimatics wakes up to $1m

University of Washington medtech spinout Perimatics will develop an anaesthesia monitoring platform that could improve care outcomes.

NGFI balances additional licence

Medical University of Graz spinout NGFI has licensed additional research conducted by its scientific founders that enables the determination of potassium levels in the human body.

Yorkshire to benefit from $40m

University of York and its peers across Yorkshire are calling on local businesses to take advantage of the provision of an extra $40m in government funding for knowledge transfer.

Arsanis closes IPO at $46m

The monoclonal antibody developer, which counts EMBL Ventures and GV among its investors, had initially raised $40m when it floated last week.

Satt Sud-Est partners Skema Business School

The partnership aims to connect researchers, student entrepreneurs, managers and business developers with a view of generating more companies.

Toker to leave Washington University

Washington University is seeking a new director for its Skandalaris Center, following Emre Toker's decision to step down next month.

Elpis Biomed extracts funding

The Cambridge spinout is commercialising research into better techniques for extracting quality stem cells, having raised a reported $464,000 in seed funding.

OSI beams into First Light Fusion

Oxford Sciences Innovation has taken Parkwalk Advisors’ stake in nuclear fusion spinout First Light Fusion.

Give and Take cultivates $2.2m seed round

Give and Take has marked the beta release of its occupational networking platform Givitas, which aims to foster a giving culture in the workforce.

Digital health ecosystem in Singapore

Lata Hariharan takes an in-depth look at Singapore's health technology ecosystem, ranging from a host of spinouts to various government initiatives.

Arsanis attains public market status with $40m IPO

The EMBL Ventures-backed immunotherapy developer floated in an underpriced offering and received $20m in a private placement from NEA.

Copyright Mawsonia Limited 2010. Please don´t cut articles from www.globaluniversityventuring.com or the PDF and redistribute by email or post to the web without written permission.

  • Linkedin
  • Mail
  • Rssfeed